<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83861">
  <stage>Registered</stage>
  <submitdate>28/04/2009</submitdate>
  <approvaldate>2/06/2009</approvaldate>
  <actrnumber>ACTRN12609000401257</actrnumber>
  <trial_identification>
    <studytitle>Can We Alter Risk Factors For Oesophageal Cancer With Exercise?</studytitle>
    <scientifictitle>A randomised controlled trial of 24 weeks of moderate-intensity exercise training versus stretching among overweight males with Barrett's oesophagus to assess the effects on biochemical and hormonal factors associated with oesophageal adenocarcinoma development.</scientifictitle>
    <utrn />
    <trialacronym>The EPOC Study</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Barrett's Oesophagus</healthcondition>
    <healthcondition>Oesophageal Adenocarcinoma prevention</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Obesity</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Physiotherapy</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Oesophageal (gullet)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Moderate-intensity exercise intervention consisting of: 30 min resistance training (2 sets of 8-12 repetitions, 8 exercises including bench press, leg press, seated row, assisted chin up, assisted tricep dip, shoulder press, lunges, core stability) and 30 min of cardiovascular training (60-70% maximum heart rate, including exercise bike, treadmill). 5 sessions per week for 24 weeks. One supervised session per week performed at a hospital. Four independent sessions performed at a local private gymnasium.</interventions>
    <comparator>Stretching program. 45 min sessions, 5 times per week for 24 weeks. One supervised session per week performed at a hospital. Four independent sessions performed at home.</comparator>
    <control>Active</control>
    <interventioncode>Prevention</interventioncode>
    <interventioncode>Lifestyle</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Serum concentrations of the adipocytokines leptin and adiponectin analysed via radioimmunoassay. Blood samples will be fasting and obtained via venipuncture.</outcome>
      <timepoint>week 0, week 12, week 24</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Serum concentrations of the inflammatory cytokines: C-Reactive Protein, Tumour Necrosis Factor-Alpha and Interleukin-6 will be analysed via immunoassay from fasting blood samples, obtained via venipuncture.</outcome>
      <timepoint>week 0, week 12, week 24</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Fasting serum insulin and plasma glucose concentrations will be used to measure insulin resistance using the Quantitative Insulin Sensitivity Check Index (QUICKI) and the Reciprocal Index of Homeostasis Model Assessment (HOMA-IR) algorithms.</outcome>
      <timepoint>week 0, week 12, week 24</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Gastro-oesophageal reflux symptoms using the Gastro-oesophageal Reflux Disease Impact Scale (GIS)</outcome>
      <timepoint>week 0, week 12, week 24</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Bio-impedance analysis will measure body fat percentage, body fat mass and fat free mass. Waist to hip ratio and body mass index will also be measured to determine adiposity.</outcome>
      <timepoint>week 0, week 12, week 24</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Muscular strength with be measured via the One Repetition Maximum (1RM) test performed on the bench press and leg press.</outcome>
      <timepoint>week 0, week 12, week 24</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Peak oxygen uptake (VO2 peak) will provide a measure of cardiovascular fitness. VO2 peak will be measured via a portable metabolic analyser whilst the participant performs the Modified Shuttle Walk Test.</outcome>
      <timepoint>week 0, week 12, week 24</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Barrett's Oesophagus confirmed via the presence of intestinal metaplasia on biopsy and an abnormal appearance of the distal oesophagus via endoscopy.
Overweight or obese (Body mass index 25-34.99kg/m2)
Performing less than 60 min of moderate-intensity exercise per week for the previous 12 weeks.
No loss or gain of &gt;5kg of body weight during the previous 6 months.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Serious medical impairments including: heart disease, lung disease, neurological disease, uncontrolled hypertension, diabetes, cancer, orthopaedic injuries.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Potential participants will complete an Expression of Interest Form. Potential participants will then be contacted by researchers who will apply the inclusion and exclusion criteria, explain the study and ask for verbal consent.  Once written consent is obtained participants will enter the study and will be allocated to the 'exercise' group or the 'control' group.  Allocation will be concealed using numbered sealed opaque envelopes.</concealment>
    <sequence>The randomisation sequence will be generated using a web-based randomisation program (http://www.randomization.com)</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>5/05/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <postcode>4029</postcode>
    <postcode>4066</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Burns, Trauma and Critical Care Research Centre, School of Medicine, University of Queensland</primarysponsorname>
    <primarysponsoraddress>University of Queensland Centre for Clinical Research. Building 71/918, Royal Brisbane &amp; Women's Hospital, HERSTON, Queensland 4029</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Queensland Health - Health Practitioner Research Scheme</fundingname>
      <fundingaddress>Allied Health Clinical Education &amp; Training Unit. Level 3. Forestry House. 160 Mary Street. Brisbane, Queensland 4000</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Goodlife Health Clubs Brisbane</fundingname>
      <fundingaddress>PO Box 813
Morningside, Queensland 4170</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Queensland Sport  (UQ Sport)</fundingname>
      <fundingaddress>Building 25, The University of Queensland, Union Rd, St Lucia
PO Box 6087, St Lucia, Queensland, 4067</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>The Wesley Research Institute</fundingname>
      <fundingaddress>Level 8, East Wing, The Wesley Hospital, 451 Coronation Drive, Auchenflower, Queensland, 4066</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Royal Brisbane and Women's Hospital</othercollaboratorname>
      <othercollaboratoraddress>Royal Brisbane and Women's Hospital 
Butterfield Street, Herston, Queensland 4029</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>The Wesley Hospital</othercollaboratorname>
      <othercollaboratoraddress>The Wesley Hospital. 451 Coronation Drive Auchenflower, Queensland 4066</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Barretts oesophagus (BE) involves changes in the lining of the oesophagus and is a precursor for a type of oesophageal cancer. Obesity is a cause of BE and research suggests that certain hormones produced by fat tissue may be the mechanism through which obesity leads to cancer of the oesophagus.

Exercise training may be an effective intervention in reducing oesophageal cancer risk given the strong links between BE, obesity and metabolic disturbances. 

There is some trial evidence that moderate-intensity exercise can improve obesity related hormone levels in overweight people without BE, but to date, no such evidence exists for patients with BE.

By randomising patients with BE to either an exercise regimen or a stretching regimen, we aim to determine whether 24 weeks of moderate-intensity exercise will lead to changes in levels of certain hormones associated with oesophageal cancer development.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Brisbane and Women's Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Level 7, Block 7
Royal Brisbane and Women's Hospital 
Butterfield Street, Herston, Queensland QLD 4029</ethicaddress>
      <ethicapprovaldate>10/10/2008</ethicapprovaldate>
      <hrec>2008/110</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of Queensland Medical Research Ethics Committee</ethicname>
      <ethicaddress>Research and Research Training Division
Cumbrae-Stewart (Building 72)
The University of Queensland
Brisbane, 4072</ethicaddress>
      <ethicapprovaldate>21/10/2008</ethicapprovaldate>
      <hrec>2008001948</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Uniting Health Care Human Research Ethics Committee</ethicname>
      <ethicaddress>PO BOX 499
Toowong, Queensland 4066
1st Floor Moorlands House, The Wesley Hospital. 451 Coronation Drive Auchenflower QLD 4066</ethicaddress>
      <ethicapprovaldate>9/04/2009</ethicapprovaldate>
      <hrec>200913</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Princess Alexandra Human Research Ethics Committee</ethicname>
      <ethicaddress>Princess Alexandra Hospital, Ipswich Road, Wooloongabba, Queensland, 4102</ethicaddress>
      <ethicapprovaldate>8/07/2009</ethicapprovaldate>
      <hrec>HREC/09/QPAH/177</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>The Prince Charles Hospital Human Research &amp; Ethics Committee</ethicname>
      <ethicaddress>The Prince Charles Hospita, Rode Road, Chermside, Queensland, 4032</ethicaddress>
      <ethicapprovaldate>15/12/2009</ethicapprovaldate>
      <hrec>HREC/09/QPCH/204</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Brooke Winzer</name>
      <address>Burns, Trauma &amp; Critical Care Research Centre, Level 7, Block 6, Royal Brisbane &amp; Women's Hospital, Butterfield Street, Queensland, 4029</address>
      <phone>+61 7 36360973</phone>
      <fax>+61 7 33655192</fax>
      <email>b.winzer@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Brooke Winzer</name>
      <address>Burns, Trauma &amp; Critical Care Research Centre, Level 7, Block 6, Royal Brisbane &amp; Women's Hospital, Butterfield Street, Queensland, 4029</address>
      <phone>+61 7 36360973</phone>
      <fax>+61 7 33655192</fax>
      <email>b.winzer@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Brooke Winzer</name>
      <address>Burns, Trauma &amp; Critical Care Research Centre, Level 7, Block 6, Royal Brisbane &amp; Women's Hospital, Butterfield Street, Queensland, 4029</address>
      <phone>+61 7 36360973</phone>
      <fax>+61 7 33655192</fax>
      <email>b.winzer@uq.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>